IP Library Granted Patent US 11,026,955
Granted Patent B2
US 11,026,955 · App. 16/575,323 · Granted Jun 8, 2021

Synthetic bile acid compositions and methods

Inventors: Robert M. Moriarty (Madison, NJ); Nathaniel E. David (Madison, NJ); Nadir Ahmeduddin Mahmood (Madison, NJ)
Assignee: Allergan Sales, LLC
A61K31/575A61K38/08A61K45/06A61K47/24C07J9/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,026,955
App. No.
16/575,323
Granted
Jun 8, 2021
Kind
B2
Abstract

Bile acids and related compositions and methods of synthesis and use. More specifically, deoxycholic acid and related compositions, said compositions being free of all moieties of animal origin and free of pyrogenic moieties.

Claims (10)

1. A method for emulsifying fat in a mammal in need thereof, the method comprising administering locally to said mammal a composition comprising: a therapeutically effective amount of DCA

or a pharmaceutically acceptable salt thereof, wherein the DCA comprises a synthetic side chain of formula:

and at least one pharmaceutically acceptable excipient and/or carrier.

2. The method of claim 1 , wherein the DCA or the pharmaceutically acceptable salt thereof is present in the composition in an amount of about 0.1% w/v to about 2% w/v.

3. The method of claim 1 , wherein the composition further comprises phosphatidylcholine.

4. The method of claim 3 , wherein the phosphatidylcholine is present in the composition in an amount of up to 5% w/v.

5. The method of claim 1 , wherein the composition does not contain phosphatidylcholine.

6. The method of claim 1 , wherein the DCA, or a pharmaceutically acceptable salt thereof, is sodium deoxycholate.

7. The method of claim 1 , wherein the administering involves delivering the composition via a subcutaneous or transdermal injection.

8. The method of claim 1 , wherein the composition is administered to a region under eye, under chin, under arm, buttock, calf, back, thigh, or stomach of said mammal.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2021
From: MORIARTY, ROBERT M.; DAVID, NATHANIEL E.; MAHMOOD, NADIR AHMEDUDDIN
To: KYTHERA BIOPHARMACEUTICALS, INC.
Reel/Frame 055177/0291 →
MERGER AND CHANGE OF NAME Recorded Feb 8, 2021
From: KYTHERA BIOPHARMACEUTICALS, LLC; ALLERGAN SALES, LLC
To: ALLERGAN SALES, LLC
Reel/Frame 055177/0545 →
CHANGE OF NAME Recorded Feb 8, 2021
From: KYTHERA BIOPHARMACEUTICALS, INC.
To: KYTHERA BIOPHARMACEUTICALS, LLC
Reel/Frame 055253/0591 →
Continuity (8)
Continuation 15940941 · Mar 29, 2018
Continuation 15349573 · Nov 11, 2016
Continuation 14503273 · Sep 30, 2014
Continuation 13741212 · Jan 14, 2013
Continuation 12035339 · Feb 21, 2008
Provisional Application 60956875 · Aug 20, 2007
Provisional Application 60945035 · Jun 19, 2007
Related Publication 20200078373A1 · Mar 12, 2020